Thrombocytopenia is an unexplained complication of iron deficiency anemia. Studies have suggested that the low levels of platelets may in some instances be related to a folate or vitamin B 12 deficiency. In order to pursue this possibility, neutrophile lobe counts, bone marrow examinations, serum folate and vitamin B 12 levels, and formiminoglutamic acid (FIGLU) excretion studies were performed on 55 iron deficient anemic infants and children both with and without thrombocytopenia. Similar studies were performed on normal children. There was an increased incidence of hypersegmentation in the iron deficiency patients and a number of these children exhibited increased lobe averages. Twenty-five of the anemic children showed abnormalities of the bone marrow consistent with megaloblastic dysplasia. The serum vitamin B 12 levels were within normal limits in all patients but the serum folate level was decreased in two of them, and three children excreted increased amounts of FIGLU.
Abstracts the bleeding time and platelet adhesiveness defect found in vWd. (SPR) 53
The Role of Folate and Vitamin B 12 in the Etiology of the Thrombocytopenia of Iron Deficiency Anemia.
SANFORD LEIKIN and PARVANEH VOSSOUGH*,
Children's Hosp. of the D.C., and George Washington Univ. Sch. of Med., Washington, D.C. Thrombocytopenia is an unexplained complication of iron deficiency anemia. Studies have suggested that the low levels of platelets may in some instances be related to a folate or vitamin B 12 deficiency. In order to pursue this possibility, neutrophile lobe counts, bone marrow examinations, serum folate and vitamin B 12 levels, and formiminoglutamic acid (FIGLU) excretion studies were performed on 55 iron deficient anemic infants and children both with and without thrombocytopenia. Similar studies were performed on normal children. There was an increased incidence of hypersegmentation in the iron deficiency patients and a number of these children exhibited increased lobe averages. Twenty-five of the anemic children showed abnormalities of the bone marrow consistent with megaloblastic dysplasia. The serum vitamin B 12 levels were within normal limits in all patients but the serum folate level was decreased in two of them, and three children excreted increased amounts of FIGLU.
Although there appeared to be a slightly greater incidence of bone marrow megaloblastoid changes in the thrombocytopenic children no clear separation on a morphologic or biochemical basis could be made between those with and without a platelet deficiency. These findings indicate that although a folate or vitamin B 12 deficiency at the bone marrow level may be involved in the causation of the thrombocytopenia of iron deficiency anemia, other factors may also be important in the etiology of the complication. (SPR)
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A new oral synthetic androgen, oxymetholone (2-hydroxymethylene-17 methyl-17B hydroxy-3-androstanone), has been remarkably effective in the treatment of 5 consecutive children with aplastic anemia, including 2 unresponsive to oral testosterone. The pattern of response was similar in each patient with diminished purpura and transfusion requirement by 4-6 weeks, a reticulocytosis by 8-10 weeks, and a gradual rise in hemoglobin level to normal by 12-20 weeks. A rise in total white cells with an absolute increase in polymorphonuclear forms developed during the 6th to 12th week of treatment. Platelet levels had improved by 12-16 weeks but have remained subnormal. Three of the children with acquired aplastic anemia received oxymetholone and prednisone as their only treatment and all have maintained their improvement for from 7 to 12 months off all medication. One 16-year-old boy with acquired aplastic anemia of 18 months' duration, and unimproved following a 6-month course of sublingual testosterone propionate and splenectomy, had a characteristic response to oral oxymetholone within 10 weeks. The fifth patient, with congenital aplastic anemia, had failed to improve during a 9-month course of sublingual testosterone propionate. Within 10 weeks on oral oxymetholone he had a reticulocytosis followed by a sustained rise in hemoglobin level. Virilization was noted in the 4 pre-pubertal patients with the dosages used (2.5 to 7.0 mg/kg/ day). No advance in bone age or other side effects were observed. Oxymetholone is a useful, easily administered, new androgenic steroid for therapy of aplastic anemia and has proved effective in children unresponsive to testosterone. (SPR)
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The Adaptive 'Anemia' of Severe Protein Calorie Malnutrition (Marasmus) . NATHAN J. SMITH and ABRAHAM STEKEL*, King County Hospital, Univ. of Washington, Seattle, Wash. A reduced hemoglobin concentration with normocytic, normochromic erythrocytes commonly cocurs in severely marasmic infants. Severe marasmus has been produced in 20 piglets by feeding a balanced but restricted diet to stabilize their weight at 5 to 7 kg for up to 9 months. Eight additional piglets served as controls. Clinical, autopsy and biochemical observations show the similarity of this animal model to marasmus previously studied in human infants. Red cell indices, marrow morphology, transferrin iron, marrow iron stores and DFP 32 erythrocyte life span are all normal and fail to indicate the presence of any specific nutritional deficiency that alters the production or survival of erythrocytes in marasmus. In spite of these findings the animals have a persistent but not progressive reduction of hemoglobin concentration (10 to 11 gms % compared to 15 to 16 gms % normal). Cr 51 studies reveal a red cell mass deficit (16.5 ml/kg in 7 months, 6 kg pigs compared to 25 ml/kg in normal 6 kg pigs). The animals were stressed by controlled phlebotomy. A prompt erythropoietic response occurred with return to the prebleeding hemoglobin level. Small increases of food intake were consistently and rapidly followed by increased erythropoiesis as measured by reticulocyte counts, M:E ratio, and iron 69 kinetic studies. On the
